Cerenome, Inc. (CNSY) vs Kiora Pharmaceuticals, Inc. (KPRX)
A side-by-side comparison of Cerenome, Inc. and Kiora Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSY
Cerenome, Inc.
$1.63HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
KPRX
Kiora Pharmaceuticals, Inc.
$2.55HealthcareDelayed quote: Oct 6, 2026, 12:01 PM EDT
Total return — CNSY vs KPRX
growth of $100 · dividends reinvested · last 1yCNSY -61.5% (-61.5%/yr)KPRX -0.8% (-0.8%/yr)KPRX compounded faster over this window
CNSY KPRX
CNSY vs KPRX: by the numbers
- •KPRX is the larger company ($11M vs $11M market cap).
- •Both run net losses; KPRX's is the smaller (0.00% vs -620.70% net margin).
Metrics side by side
Valuation
| Metric | CNSY | KPRX |
|---|---|---|
| P/S ratio | 2.66 | N/A |
| P/B ratio | 2.05 | 0.67 |
Profitability
| Metric | CNSY | KPRX |
|---|---|---|
| Gross margin | 89.58% | 0.00% |
| Operating margin | -293.46% | 0.00% |
| Net margin | -620.70% | 0.00% |
| ROE | -477.54% | -65.18% |
| ROIC | -479.39% | -59.42% |
Growth (annualized)
| Metric | CNSY | KPRX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -67.06% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.